India may get the fourth corona vaccine, Pfizer is negotiating for approval

Covishield and covacin are available in India. Russia’s Sputnik V has been granted emergency clearance. Vaccination has also started for people above 18 years of age in the country from May 1.  

New Delhi:  India may get a fourth vaccine against the corona virus in the country. Pfizer, the world’s most effective vaccine maker, is in touch with India. It is currently in talks to get its corona vaccine approved in India. Pfizer is an American vaccine manufacturer that may now come to India. Many experts consider this vaccine to be the most effective against coronary heart disease. The vaccine has been shown to be 92 to 95 percent effective against corona infection in all its trials. The vaccine is called BNT162b2, which is also listed by the World Health Organization (WHO) as an effective and safe corona vaccine. 

The graph of people infected with corona virus in India is constantly going up. The death toll is also rising. The situation is out of control. In turn, the Indian government sees vaccination as the biggest way to combat corona. Covishield and covacin are currently available in India. Russia’s Sputnik V has been granted emergency clearance. Vaccination has also started for people above 18 years of age in the country from May 1. 

Before coming to India, The condition

Before coming to India, Pfizer, the company has kept a condition. Pfizer said it would provide its Covid-19 vaccine only through a government contract. This means that almost all of these vaccines are not available in private hospitals in the country unless the government provides vaccines to these private institutions. 

Pfizer’s decision comes when India has made one change after another in its covid vaccination strategy. It has given companies the option to sell the vaccine to states or private hospitals at a slightly higher price. A Pfizer spokesperson said the company would make the vaccine available in India but would prioritise government vaccination programs in this time of the epidemic. 

Leave a Reply

Your email address will not be published. Required fields are marked *